Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03482011
Brief Title: A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-1)

First Submitted : March 23, 2018
First Submitted that Met QC Criteria : March 23, 2018
First Posted : March 29, 2018

Results First Submitted : August 31, 2020
Results First Submitted that Met QC Criteria : August 31, 2020
Results First Posted : September 25, 2020

Certification/Extension First Submitted : March 6, 2020
Certification/Extension First Submitted that Met QC Criteria : March 6, 2020
Certification/Extension First Posted : March 11, 2020

Last Update Submitted that Met QC Criteria : August 31, 2020
Last Update Posted : September 25, 2020